Implantable Provider Group, a leading provider of implantable device management, announced that it has secured an investment from Sequoia Capital, which will enable IPG to invest in future growth initiatives, according to an IPG news release.
IPG streamlines the management and delivery of implantable medical devices through its Implantable Device Management solution, working directly with commercial payors, clinical providers and medical device makers to minimize the complexity and financial risks associated with the billing and reimbursement of implantable devices.
“Our services are directly in line with the needs of the healthcare industry right now,” Jay Ethridge, CEO of IPG, said in the release. “Given the current environment, it is critical that commercial insurance companies find ways to reduce costs without compromising patient care. IPG enables payers to do exactly that by reducing the cost of implantable devices without any change in the delivery of care.”
“We are excited to be working with IPG,” Scott Carter, general partner at Sequoia Capital, said in the release. “The company is addressing a significant need in the healthcare industry.”
Learn more about IPG.
